Shareholders' Equity (Details) - Warrant |
12 Months Ended |
---|---|
Dec. 31, 2015
$ / shares
shares
| |
Additional information for warrants outstanding | |
Number of warrants, outstanding at December 31, 2014 | shares | 21,239,213 |
Weighted average exercise price, outstanding at December 31, 2014 | $ / shares | $ 0.75 |
Number of warrants, exercised | shares | (19,034,662) |
Weighted average exercise price, exercised | $ / shares | $ 0.74 |
Number of warrants, expired | shares | (30,828) |
Weighted average exercise price, expired | $ / shares | $ 0.01 |
Number of warrants, outstanding and exercisable at December 31, 2015 | shares | 2,173,723 |
Weighted average exercise price, outstanding and Exercisable at December 31, 2015 | $ / shares | $ 0.85 |
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercised weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments expired weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
X | ||||||||||
- Details
|